News und Analysen
FIGEAC AÉRO: FIGEAC AÉRO NORTH AMERICA DRIVES FURTHER LOCAL GROWTH WITH A NEW BUSINESS JET WIN WITH GKN AEROSPACE
Sartorius Stedim Biotech SA: DECLARATION RELATIVE TO THE NUMBER OF SHARES AND VOTING RIGHTS MAKING UP THE ISSUED CAPITAL
Medidata Advances New Frontiers for Life Sciences Through Patient-Centric Experiences, AI-Powered Innovations, and New Patient Engaging Alliances
Medidata, a Dassault Systèmes brand, reaffirms its vision and commitment to advancing the life sciences industry and transforming patient experiences across the entire clinical development process
Dassault Systèmes and Volkswagen Group Implement the 3DEXPERIENCE Platform to Optimize Vehicle Development
Dassault Systèmes (Euronext Paris: FR0014003TT8, DSY.PA) and Volkswagen Group today announced a long-term partnership to advance Volkswagen Group’s digital infrastructure for state-of-the-art
Dassault Systèmes Reveals “3D UNIV+RSES” and Related AI-Based Services
Dassault Systèmes (Euronext Paris: FR0014003TT8, DSY.PA) today opened up its new horizon as part of the Generative Economy by introducing “3D UNIV+RSES” that embed multiple generative AI
BILENDI: Bilendi announces the completion of the acquisition of Netquest
Median Technologies: eyonis™ Lung Cancer Screening (LCS) Meets Primary Endpoint in RELIVE Clinical Trial, the Final Pivotal Study Required for Regulatory Submissions
Regulatory News:
Median Technologies (Paris:ALMDT):
Fredrik Brag, CEO of Median Technologies, will host two webcasts on February 4, 2025
“New Horizons in Fighting Lung Cancer: eyonis™ LCS
Median Technologies Reports 2024 Key Financial Indicators and 2025 Outlook
Regulatory News:
Median Technologies (FR0011049824, ALMDT, PEA/SME scheme eligible), a leading developer of eyonis™, a suite of artificial intelligence (AI) powered Software as a Medical Device
Poxel’s partner Sumitomo Pharma reports TWYMEEG® gross sales in Japan for Q4 2024 and FY 2024 sales forecast
Regulatory News:
POXEL SA (Euronext : POXEL - FR0012432516), a clinical stage biopharmaceutical company developing innovative treatments for chronic serious diseases with metabolic
FIGEAC AÉRO: 9M 2024/25 REVENUE: €303.0 MILLION, +9.6% - PILOT 28 TARGETS REVISED UPWARDS
EQS-News: Abivax Publishes 2025 Financial Calendar
Sartorius Stedim Biotech publishes preliminary, unaudited results for fiscal 2024
Bureau Veritas - Statement
In a statement issued on January 15th, 2025, Bureau Veritas and SGS communicated that they had engaged in discussions with regards to a potential business combination.
Today, Bureau Veritas
Median Technologies securing up to €47.5 million to support AI lung cancer diagnostic eyonis™ regulatory filings and commercialization in U.S. and EU
Regulatory News:
Median Technologies (FR0011049824, ALMDT, PEA/SME eligible, “Median” or “The Company”), a leading developer of eyonis™, a suite of artificial intelligence (AI) powered Software
EQS-News: Abivax Announces Presentation of Seven Abstracts for Obefazimod in Ulcerative Colitis at 2025 European Crohn’s and Colitis Organization 20th Annual Congress
GenSight Biologics Reports End-of-Year Cash Position and Provides Business Update
Regulatory News:
GenSight Biologics ("GenSight Biologics" or the "Company") (Euronext: SIGHT, ISIN: FR0013183985, PEA-PME eligible), a biopharma company focused on developing and commercializing
Eutelsat Partners with NIGCOMSAT to Launch LEO Satellite Services in Nigeria
Regulatory News:
Eutelsat Group (ISIN: FR0010221234 - Euronext Paris / London Stock Exchange: ETL), a global leader in satellite communications and Nigerian Communications Satellite Limited
Poxel to receive sales-based payment and higher level of royalties from Sumitomo Pharma in Q1 2025 for TWYMEEG® Achieving JPY 5 billion Net Sales in Japan
Regulatory News:
POXEL SA (Euronext : POXEL - FR0012432516), a clinical stage biopharmaceutical company developing innovative treatments for chronic serious diseases with metabolic
PULLUP ENTERTAINMENT : Record Q3 2024/25 revenue of €100.8 million.
BILENDI: Launch of Bilendi Platform: Redefining Efficiency in Market Research
Medidata Expands Leadership Team to Drive Patient-Centered and Customer-Focused Innovation
Medidata, a Dassault Systèmes brand and leading provider of clinical trial solutions to the life sciences industry, has named Alicia Staley as chief patient officer and senior vice president
Verimatrix gibt Einführung der Over-the-Air-CAS-Nachrüstlösung DVB ReAccess bekannt
Verimatrix, (Euronext Paris: VMX, FR0010291245), das führende Unternehmen im Bereich der modernen vernetzten Welt mit menschenzentrierter Sicherheit, gab heute die allgemeine Verfügbarkeit seiner
Bureau Veritas: Statement
Following recent media commentary, Bureau Veritas indicates that it is in discussions with SGS regarding a potential business combination. There can be no assurance that these discussions will